Last reviewed · How we verify
Ifosphamide, Etoposide, Methotrexate, Vincristine, Prednisone
At a glance
| Generic name | Ifosphamide, Etoposide, Methotrexate, Vincristine, Prednisone |
|---|---|
| Also known as | Protocol B |
| Sponsor | Children's Cancer Group, China |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- BNHL-2015 for Children or Adolescents in China (PHASE2, PHASE3)
- Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: